3-[2-(2-methylprop-2-enoyloxy)ethylcarbamoyloxy]propyl 2-methylprop-2-enoate
C14H21NO6 — CID 155928177
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[2-(2-methylprop-2-enoyloxy)ethylcarbamoyloxy]propyl 2-methylprop-2-enoate
3-[2-(2-methylprop-2-enoyloxy)ethylcarbamoyloxy]propyl 2-methylprop-2-enoate (PubChem CID 155928177) has the molecular formula C14H21NO6 and a molecular weight of 299.32 g/mol. Its IUPAC name is 3-[2-(2-methylprop-2-enoyloxy)ethylcarbamoyloxy]propyl 2-methylprop-2-enoate.
Molecular Properties
| Compound Name | 3-[2-(2-methylprop-2-enoyloxy)ethylcarbamoyloxy]propyl 2-methylprop-2-enoate |
|---|---|
| PubChem CID | 155928177 |
| Molecular Formula | C14H21NO6 |
| Molecular Weight | 299.32 g/mol |
| Exact Mass | 299.14 |
| IUPAC Name | 3-[2-(2-methylprop-2-enoyloxy)ethylcarbamoyloxy]propyl 2-methylprop-2-enoate |
| SMILES | C=C(C)C(=O)OCCCOC(=O)NCCOC(=O)C(=C)C |
| InChI | InChI=1S/C14H21NO6/c1-10(2)12(16)19-7-5-8-21-14(18)15-6-9-20-13(17)11(3)4/h1,3,5-9H2,2,4H3,(H,15,18) |
| InChIKey | FFLOROHZWLAYMI-UHFFFAOYSA-N |
| XLogP | 1.34 |
| TPSA | 90.93 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 299.32 |
| LogP ≤ 5 | 1.34 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155928177 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.